Cardiovascular disease remains the leading cause of death globally, accounting for approximately 18 million deaths annually. While pharmaceutical interventions dominate clinical cardiology, several nutritional supplements have strong evidence for meaningful cardiovascular benefits - both as standalone interventions and in combination with optimal lifestyle behaviours.
Omega-3 Fatty Acids: The Strongest Evidence
Omega-3 supplementation has the most robust cardiovascular evidence of any supplement class. Key mechanisms include triglyceride reduction (consistent 15 - 30% reduction with 2 - 4g EPA+DHA daily), anti-arrhythmic effects (membrane stabilisation reducing cardiac arrhythmia risk), anti-platelet aggregation (reduces thrombosis risk), and endothelial function improvement (vasodilation via nitric oxide upregulation).
The REDUCE-IT trial (2018, NEJM) - involving 8,179 patients with elevated triglycerides on statin therapy - found high-dose EPA (4g/day) reduced major cardiovascular events by 25% and cardiovascular death by 20%. The absolute risk reduction was clinically significant.
CoQ10: Heart Muscle Energy
The heart muscle has the highest CoQ10 concentration of any tissue - because it has the highest energy demands. Heart failure is consistently associated with significantly depleted cardiac CoQ10 levels. The Q-SYMBIO trial (2014) found 300mg/day CoQ10 reduced cardiovascular events by 43% and cardiovascular mortality by 42% in heart failure patients. For preventive cardiovascular health, 100 - 200mg daily supports mitochondrial function and protects against cardiac oxidative stress.
Magnesium: The Electrolyte of the Heart
Magnesium regulates cardiac rhythm by modulating potassium and calcium channels in cardiac muscle cells. Hypomagnesaemia (low blood magnesium) is associated with arrhythmias, hypertension, and increased risk of sudden cardiac death. Population studies consistently show inverse associations between dietary magnesium intake and cardiovascular mortality. Supplementation reduces blood pressure by an average of 3 - 4 mmHg systolic in meta-analyses - modest but meaningful for long-term risk.
Resveratrol
Beyond its longevity effects, resveratrol improves endothelial function, reduces LDL oxidation (oxidised LDL is the atherogenic form), and inhibits platelet aggregation. A 2016 meta-analysis found significant reductions in systolic blood pressure and LDL cholesterol with resveratrol supplementation.